A DFT study of Graphene as a drug carrier for gemcitabine anticancer drug

被引：1

作者：

Abahussain, Abdulaziz A. M. ^{[1
]}

Zaidi, S. Z. J. ^{[2
]}

Nazir, M. H. ^{[2
,3
]}

Raza, M. ^{[2
]}

Hassan, S. ^{[4
]}

机构：

[1] King Saud Univ, Dept Chem Engn, Riyadh, Saudi Arabia

[2] Univ Punjab, Inst Chem Engn & Technol, Lab Energy Water & Healthcare Technol, Lahore 54000, Punjab, Pakistan

[3] Univ South Wales, Fac Comp Engn & Sci, Caerleon, Wales

[4] Univ Hong Kong, Dept Mech Engn, Hong Kong, Peoples R China

来源：

JOURNAL OF NEW MATERIALS FOR ELECTROCHEMICAL SYSTEMS | 2022年 / 25卷 / 04期

关键词：

gemcitabine; graphene; density functional theory; drug delivery;

D O I：

10.14447/jnmes.v25i4.a02

中图分类号：

O646 [电化学、电解、磁化学];

学科分类号：

081704 ;

摘要：

Research is being carried out worldwide for possible treatment of cancer. Graphene has been studied as a drug carrier for various cancer-related drugs [1-2]. In the present work, we apply theoretical models to study the electrons interactions, thermodynamic properties, and solvent interaction of the drug-carrier configuration. The stability of graphene means that it can be a nanocarrier in the biological system. The simulations result shows that graphene provides a stable base, where gemcitabine is a highly dissolvable and reactive drug. The adsorption of gemcitabine on the graphene was physical. The drug carrier configuration formed a highly impactful drug-carrier design.

引用

页码：234 / 239

页数：6

共 50 条

[31] Ab initio study on the noncovalent adsorption of camptothecin anticancer drug onto graphene, defect modified graphene and graphene oxide
Nabanita Saikia
Ramesh C. Deka
Journal of Computer-Aided Molecular Design, 2013, 27 : 807 - 821
[32] Ab initio study on the noncovalent adsorption of camptothecin anticancer drug onto graphene, defect modified graphene and graphene oxide
Saikia, Nabanita
Deka, Ramesh C.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2013, 27 (09) : 807 - 821
[33] On the possibility of using the Ti@Si16 superatom as a novel drug delivery carrier for different drugs: A DFT study
Zhang, Li
Zhang, Jia-Chen
Shi, Ling-Fei
Cheng, Xin
Chen, Jing-Hua
Sun, Wei-Ming
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2023, 118
[34] Covalent organic framework as smart and high efficient carrier for anticancer drug delivery: a DFT calculations and molecular dynamics simulation study
Hashemzadeh, Hassan
Raissi, Heider
JOURNAL OF PHYSICS D-APPLIED PHYSICS, 2018, 51 (34)
[35] Si-doped phagraphene as a drug carrier for adrucil anti-cancer drug: DFT studies
Bagheri, Rayehe
Babazadeh, Mirzaagha
Vessally, Esmail
Es'haghi, Moosa
Bekhradnia, Ahmadreza
INORGANIC CHEMISTRY COMMUNICATIONS, 2018, 90 : 8 - 14
[36] Circadian physiology is a toxicity target of the anticancer drug gemcitabine in mice
Li, X. M.
Levi, F.
JOURNAL OF BIOLOGICAL RHYTHMS, 2007, 22 (02) : 159 - 166
[37] Molecular insight into the role of benzotriazole nanocapsule to deliver anticancer drug in smart drug delivery system
Sajjad, Areeg
Sarfaraz, Sehrish
Hamid, Malai Haniti Sheikh Abdul
Keasberry, Natasha A.
Lakhani, Ahmed
Sheikh, Nadeem S.
Ayub, Khurshid
SCIENTIFIC REPORTS, 2025, 15 (01):
[38] In vitro genotoxic effects of the anticancer drug gemcitabine in human lymphocytes
Aydemir, N
Çelikler, S
Bilaloglu, R
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2005, 582 (1-2) : 35 - 41
[39] Functionalized Graphene Platforms for Anticancer Drug Delivery
Sattari, Shabnam
Adeli, Mohsen
Beyranvand, Siamak
Nemati, Mohammad
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 5955 - 5980
[40] Computational investigation of graphyne monolayer as a promising carrier for anticancer drug delivery
Al-Qaaneh, Ayman M.
Abosaoda, Munthar Kadhim
Baldaniya, Lalji
Abd Hamid, Junainah
Sabarivani, A.
Panigrahi, Rajashree
Shankhyan, Aman
Alajmi, M. F.
Bekhit, Mounir M.
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2025, 115

← 1 2 3 4 5 →